Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

NCT01356706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2012-07-03

No results posted yet for this study

Summary

Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.

Conditions

  • Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

Sponsors & Collaborators

  • University Hospital, Gasthuisberg

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2008-12-31
Completion
2012-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01356706 on ClinicalTrials.gov